Soria Ester Banque - 06 Feb 2024 Form 4 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Feb 2024, 16:35:11 UTC
Prior SEC filing
02 Aug 2023
Next SEC filing
09 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lauren Luptak, as Attorney-in-Fact

Key filing fact

Soria Ester Banque filed Form 4 for Zoetis Inc. (ZTS) on 08 Feb 2024.

Key facts

  • This page summarizes Soria Ester Banque's Form 4 filing for Zoetis Inc. (ZTS).
  • 2 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 08 Feb 2024, 16:35.

Change

  • Previous filing in this sequence was filed on 02 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+1,433
Change %
Price
$0.000000
Shares after
1,433
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,433
Exercise price
Footnotes
F1, F2, F3, F4
ZTS transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+5,514
Change %
Price
$0.000000
Shares after
5,514
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,514
Exercise price
$196.14
Footnotes
F6, F7, F8
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,671
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,671
Exercise price
Footnotes
F1, F2, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F2

Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, July 31, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F6

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Footnote F7

One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.

Footnote F8

Each option expires on the tenth anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .